Davis Blaine 4
4 · Protara Therapeutics, Inc. · Filed Sep 23, 2020
Insider Transaction Report
Form 4
Davis Blaine
Chief Financial Officer
Transactions
- Purchase
Common Stock
2020-09-22$16.91/sh+1,481$25,038→ 1,481 total
Footnotes (1)
- [F1]The price reported in Column 4 is weighted average price. These shares were purchased in multiple transactions at prices ranging from $16.885 to $16.935, inclusive. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information will be provided regarding the number of shares purchased or sold at each separate price.